Aquatic Capital Management LLC lessened its stake in Vital Farms, Inc. (NASDAQ:VITL - Free Report) by 58.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 79,696 shares of the company's stock after selling 113,504 shares during the period. Aquatic Capital Management LLC owned approximately 0.18% of Vital Farms worth $3,004,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently made changes to their positions in the stock. CIBC Private Wealth Group LLC increased its stake in Vital Farms by 152.1% in the fourth quarter. CIBC Private Wealth Group LLC now owns 895 shares of the company's stock valued at $35,000 after acquiring an additional 540 shares during the last quarter. US Bancorp DE raised its holdings in shares of Vital Farms by 160.3% during the 4th quarter. US Bancorp DE now owns 1,416 shares of the company's stock valued at $53,000 after buying an additional 872 shares in the last quarter. Frazier Financial Advisors LLC bought a new stake in Vital Farms in the 4th quarter worth approximately $59,000. Mendota Financial Group LLC purchased a new stake in Vital Farms in the fourth quarter worth approximately $62,000. Finally, Principal Securities Inc. raised its stake in shares of Vital Farms by 29.4% during the fourth quarter. Principal Securities Inc. now owns 1,673 shares of the company's stock worth $63,000 after acquiring an additional 380 shares in the last quarter. Hedge funds and other institutional investors own 98.59% of the company's stock.
Insider Transactions at Vital Farms
In other Vital Farms news, CEO Russell Diez-Canseco sold 45,124 shares of the company's stock in a transaction dated Monday, April 14th. The stock was sold at an average price of $33.69, for a total value of $1,520,227.56. Following the completion of the sale, the chief executive officer now owns 703,736 shares in the company, valued at $23,708,865.84. This represents a 6.03 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Matthew Ohayer sold 4,000 shares of the firm's stock in a transaction that occurred on Monday, March 24th. The stock was sold at an average price of $31.39, for a total transaction of $125,560.00. Following the sale, the insider now owns 6,966,890 shares in the company, valued at approximately $218,690,677.10. The trade was a 0.06 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 93,124 shares of company stock worth $3,019,308 over the last three months. 27.60% of the stock is currently owned by company insiders.
Vital Farms Stock Performance
Shares of VITL stock opened at $33.38 on Monday. Vital Farms, Inc. has a 12 month low of $24.87 and a 12 month high of $48.41. The stock has a market cap of $1.49 billion, a PE ratio of 29.80 and a beta of 0.96. The company's fifty day moving average price is $32.16 and its 200-day moving average price is $35.36. The company has a current ratio of 3.24, a quick ratio of 2.81 and a debt-to-equity ratio of 0.04.
Vital Farms (NASDAQ:VITL - Get Free Report) last released its earnings results on Thursday, February 27th. The company reported $0.23 EPS for the quarter, topping the consensus estimate of $0.15 by $0.08. The business had revenue of $165.99 million for the quarter, compared to the consensus estimate of $160.32 million. Vital Farms had a return on equity of 22.29% and a net margin of 8.68%. On average, equities analysts expect that Vital Farms, Inc. will post 1.11 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
Several equities analysts recently commented on VITL shares. DA Davidson reduced their target price on shares of Vital Farms from $44.00 to $42.00 and set a "buy" rating on the stock in a report on Friday, March 14th. Morgan Stanley lowered their target price on Vital Farms from $40.00 to $39.00 and set an "overweight" rating for the company in a research note on Thursday, April 17th. TD Cowen boosted their price objective on Vital Farms from $41.00 to $45.00 and gave the company a "buy" rating in a research report on Wednesday, January 8th. Telsey Advisory Group reaffirmed an "outperform" rating and issued a $52.00 target price on shares of Vital Farms in a research note on Thursday, March 13th. Finally, Stifel Nicolaus raised shares of Vital Farms from a "hold" rating to a "buy" rating and set a $44.00 price target on the stock in a report on Friday, February 28th. Eight equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, Vital Farms has a consensus rating of "Buy" and a consensus price target of $44.71.
Read Our Latest Stock Analysis on VITL
About Vital Farms
(
Free Report)
Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Vital Farms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.
While Vital Farms currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.